|
Bio:
Keh-Ming Lin is a psychiatrist who has served on the UCLA School of Medicine faculty since he joined the Department of Psychiatry and Biobehavioral Sciences in 1979. He became a full professor in 1992 and has been a professor Emeritus since 2004. Dr. Lin served as Director for the NIMH/Harbor-UCLA Research Center on the Psychobiology of Ethnicity from 1990 to 2004, and has been a Distinguished Investigator and Director of the Division of Mental Health and Substance Abuse Research at the National Health Research Institutes in Taiwan from 2004 to 2008. He is currently a Fellow at the Center for Advanced Study in the Behavioral Sciences at Stanford (CASBS). Honors received include the appointment as an Honorary Professor, Hunan Medical University; William Sargant Lecturer, Royal College of Psychiatrists, and the American Psychiatric Association?s Kung-Po Soo Asian American Award. Dr. Lin earned his B.M. in Medicine at the National Taiwan University, Taiwan, and completed his psychiatric residency at the University of Washington, Seattle, where he subsequently entered the Robert Wood Johnson Clinical Scholars Program, and received his M.P.H. degree as well as residency training in preventive medicine. Dr. Lin has been engaged in clinical and translational research for over three decades. In addition to original works in cross-ethnic psychopharmacology and psychiatric nosology, he also has made significant contributions in epidemiology, medical anthropology and refugee research, translated major psychiatric classics that are still in print, and is the founder of two major Asian mental health centers in Los Angeles. As one of the first to demonstrate significant ethnic and individual variations in the metabolism and effects of psychotropics, he has been the PI of a large number of NIH grants, and served as Director and PI of a research center that has been continuously funded by NIMH for over a decade. He authored more than 100 original research articles, 74 invited review articles and book chapters, and 11 books. He also has serves on the advisory boards of a number of important organizations, including the FDA, APA?s Council on Research, DSM-V Workgroups, and the Program for Minority Research Training in Psychiatry.
|
